Pilot Study to Evaluate "Intégrer et Accompagner Les Consommations d'Alcool!" (IACA!)'s Impact and Transferability (VITAE)
Pilot Study to Evaluate Impact and Transferability of an Alcohol Focused Harm Reduction Support System Based on Mental Health Recovery Named IACA!
In France, alcohol consumption is the second most common cause of so-called preventable cancers after tobacco. Since 2014, in the "Provence-Alpes-Côte d'Azur" (PACA) region, the association Santé! has been developing an innovative intervention to support people suffering from alcohol-related addiction. This intervention, called IACA! must therefore be evaluated on a larger scale before conclusions about its effectiveness can be drawn from a comparative trial.
This evaluation requires significant human and material resources. It is therefore recommended to first assess the transferability of IACA! in other care centers in a pilot study.
調査の概要
詳細な説明
In France, 11% of cancers in men and 4.5% of cancers in women are attributed to alcohol consumption. It is the second leading cause of so-called preventable cancers, accounting for 28,000 alcohol-related cancers out of 352,000 new cases of cancer affecting annually adults (over 30 years of age). Overall, alcohol is among the top 3 factors contributing to Disability-Adjusted life year (DALYs) in France in 2017. Some cancer risks can be quantified as early as one drink a day (oesophagus, oral cavity, pharynx and breast in women). However, the risks associated with alcohol consumption remain influenced by the quantities consumed. There is therefore an interest, particularly for consumers of the largest quantities, in reducing the quantities consumed. In Europe, while people who drink more than 60 g/d of alcohol for men and 40 g/d for women are estimated to represent only 16.1% of the population for men and 9.3% for women, they represent 87% and 82% of alcohol-related morbidity and mortality respectively. Subjects with addiction (or substance use disorders) have an increased risk of social harm (1.5 to 3 times that of alcohol users without addiction), a higher mortality (1.4 to 6.5 compared to the general population) with a life expectancy of 9 to 20 years shorter than that of the general population. Moreover, even if the quantities consumed are not a valid individual diagnostic criterion, studies show a strong association between the quantity consumed and the diagnosis of addiction. Finally, some studies suggest that the prevalence of secondary harm from alcohol use follows an exponential curve as a function of alcohol consumption.
Since 2014, in the PACA region, the association Santé! has been developing an intervention to support people suffering from alcohol-related addiction. This intervention, called IACA! (Integrating and supporting alcohol consumption), differs from the support provided during rehabilitation cures and aims to: fight against discrimination and exclusion of people who drink alcohol, re-engage these individuals in the care process (because they have generally left it) by using the appropriate levers, promote well-being, improve quality of life and recovery and support the recovery in control of consumption. Thus, IACA!, through its philosophy and implementation, is based both on the risk reduction approach historically deployed with drug users and on the recovery approach, developed in the field of mental health. The first one-year results of this program were promising since, of 17 people who received the intervention, all had a social or health benefit, 13 of whom were associated with stabilization (n=4), reduction (n=7) or cessation (n=2) of alcohol use.
These promising results must therefore be evaluated on a larger scale before conclusions about its effectiveness can be drawn from a comparative trial. This type of evaluation requires significant human and material resources. It is therefore recommended to first assess in the field: 1) the conditions under which such an intervention is deployed in other centres (adaptations implemented by other centres to deploy IACA! for example, without distorting the intervention), 2) the acceptability and feasibility of the intervention in other centres (are the human and material resources on site sufficient for the successful deployment of the intervention?), 3) the acceptability and feasibility of the large-scale evaluation envisaged.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
-
Bordeaux、フランス
- CH Perrens - Equipe Addiction
-
Bordeaux、フランス
- MéRISP - Université U1219
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
This research will investigate three types of populations:
- Individuals receiving support from the IACA! Intervention (called beneficiaries),
- Professionals implementing the IACA! Intervention i.e. the pairs in charge of accompanying the beneficiaries in the centers as well as the persons in charge of these centers,
- Professionals from Santé! supporting the deployment of the IACA! intervention.
The beneficiaries are all persons integrating the program in the project's partner sites and consuming alcohol.
The professionals will be specialized educators, social workers, nurses, social and solidarity economy advisors, etc.
説明
Inclusion criteria common to the 3 populations:
- Over 18 years of age
- whatever the gender
- Non-opposition to participate
Inclusion criteria for professionals from centers implementing IACA! :
Concerning professionals in contact with the patients:
- Having been trained at IACA!
- Working in the centers participating in the implementation of IACA!
Concerning the persons in charge of the centers :
These professionals are those who have participated in the deployment of the IACA! method in their centers
Criteria for the inclusion of health professionals ! Participating or having recently participated in the implementation of IACA!
Exclusion Criteria:
The beneficiaries will be excluded if they have a severe somatic or psychiatric pathology that is incompatible with understanding the assessment tools; difficulty understanding and/or writing French; if they are unreachable by telephone, if they are participating in another research project with an ongoing exclusion period, if they are placed under court protection and if they are pregnant.
研究計画
研究はどのように設計されていますか?
デザインの詳細
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Severity of alcohol use
時間枠:12 months after the start of IACA
|
12 months after the start of IACA
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Utility dimension of viability - alcohol consumption
時間枠:Baseline (M0)
|
Average number of units of alcohol consumption in the past 30 days
|
Baseline (M0)
|
|
Utility dimension of viability - alcohol consumption
時間枠:3 months (M3)
|
Average number of units of alcohol consumption in the past 30 days
|
3 months (M3)
|
|
Utility dimension of viability - alcohol consumption
時間枠:6 months (M6)
|
Average number of units of alcohol consumption in the past 30 days
|
6 months (M6)
|
|
Utility dimension of viability - alcohol consumption
時間枠:9 months (M9)
|
Average number of units of alcohol consumption in the past 30 days
|
9 months (M9)
|
|
Utility dimension of viability - alcohol consumption
時間枠:12 months (M12)
|
Average number of units of alcohol consumption in the past 30 days
|
12 months (M12)
|
|
Utility dimension of viability - craving
時間枠:Baseline (M0)
|
Craving: average frequency and intensity in the last 30 days
|
Baseline (M0)
|
|
Utility dimension of viability - craving
時間枠:3 months (M3)
|
Craving: average frequency and intensity in the last 30 days
|
3 months (M3)
|
|
Utility dimension of viability - craving
時間枠:6 months (M6)
|
Craving: average frequency and intensity in the last 30 days
|
6 months (M6)
|
|
Utility dimension of viability - craving
時間枠:9 months (M9)
|
Craving: average frequency and intensity in the last 30 days
|
9 months (M9)
|
|
Utility dimension of viability - craving
時間枠:12 months (M12)
|
Craving: average frequency and intensity in the last 30 days
|
12 months (M12)
|
|
Utility dimension of viability - severity
時間枠:Baseline (M0)
|
Severity score for addictive substances and behaviors
|
Baseline (M0)
|
|
Utility dimension of viability - severity
時間枠:3 months (M3)
|
Severity score for addictive substances and behaviors
|
3 months (M3)
|
|
Utility dimension of viability - severity
時間枠:6 months (M6)
|
Severity score for addictive substances and behaviors
|
6 months (M6)
|
|
Utility dimension of viability - severity
時間枠:9 months (M9)
|
Severity score for addictive substances and behaviors
|
9 months (M9)
|
|
Utility dimension of viability - severity
時間枠:12 months (M12)
|
Severity score for addictive substances and behaviors
|
12 months (M12)
|
|
Utility dimension of viability - disorders
時間枠:Baseline (M0)
|
Presence of alcohol and other substance use disorders (past 12 months and past)
|
Baseline (M0)
|
|
Utility dimension of viability - disorders
時間枠:3 months (M3)
|
Presence of alcohol and other substance use disorders (past 12 months and past)
|
3 months (M3)
|
|
Utility dimension of viability - disorders
時間枠:6 months (M6)
|
Presence of alcohol and other substance use disorders (past 12 months and past)
|
6 months (M6)
|
|
Utility dimension of viability - disorders
時間枠:9 months (M9)
|
Presence of alcohol and other substance use disorders (past 12 months and past)
|
9 months (M9)
|
|
Utility dimension of viability - disorders
時間枠:12 months (M12)
|
Presence of alcohol and other substance use disorders (past 12 months and past)
|
12 months (M12)
|
|
Utility dimension of viability - Other substances
時間枠:Baseline (M0)
|
Number of days of use of other substances/behaviours in the past 30 days
|
Baseline (M0)
|
|
Utility dimension of viability - Other substances
時間枠:3 months (M3)
|
Number of days of use of other substances/behaviours in the past 30 days
|
3 months (M3)
|
|
Utility dimension of viability - Other substances
時間枠:6 months (M6)
|
Number of days of use of other substances/behaviours in the past 30 days
|
6 months (M6)
|
|
Utility dimension of viability - Other substances
時間枠:9 months (M9)
|
Number of days of use of other substances/behaviours in the past 30 days
|
9 months (M9)
|
|
Utility dimension of viability - Other substances
時間枠:12 months (M12)
|
Number of days of use of other substances/behaviours in the past 30 days
|
12 months (M12)
|
|
Utility dimension of viability - Inventory
時間枠:Baseline (M0)
|
Inventory of medical, psychosocial and psycho-educational contacts in the last 30 days
|
Baseline (M0)
|
|
Utility dimension of viability - Inventory
時間枠:3 months (M3)
|
Inventory of medical, psychosocial and psycho-educational contacts in the last 30 days
|
3 months (M3)
|
|
Utility dimension of viability - Inventory
時間枠:6 months (M6)
|
Inventory of medical, psychosocial and psycho-educational contacts in the last 30 days
|
6 months (M6)
|
|
Utility dimension of viability - Inventory
時間枠:9 months (M9)
|
Inventory of medical, psychosocial and psycho-educational contacts in the last 30 days
|
9 months (M9)
|
|
Utility dimension of viability - Inventory
時間枠:12 months (M12)
|
Inventory of medical, psychosocial and psycho-educational contacts in the last 30 days
|
12 months (M12)
|
|
Utility dimension of viability - QoL
時間枠:Baseline (M0)
|
Quality of life
|
Baseline (M0)
|
|
Utility dimension of viability - QoL
時間枠:3 months (M3)
|
Quality of life
|
3 months (M3)
|
|
Utility dimension of viability - QoL
時間枠:6 months (M6)
|
Quality of life
|
6 months (M6)
|
|
Utility dimension of viability - QoL
時間枠:9 months (M9)
|
Quality of life
|
9 months (M9)
|
|
Utility dimension of viability - QoL
時間枠:12 months (M12)
|
Quality of life
|
12 months (M12)
|
|
Conditions of transferability
時間枠:9 to 12 months (M9 to M12)
|
Conditions of transferability linked to the characteristics of the stakeholders and the context: contextual conditions for success within the centres, the characteristics of professionals and patients influencing outcomes
|
9 to 12 months (M9 to M12)
|
|
Viability and implementation
時間枠:6 to 12 months (M6 to M12)
|
Implementation of IACA! (process, resources, activities) including the respect of IACA! success principles (skills, postures)
|
6 to 12 months (M6 to M12)
|
|
Viability and utility
時間枠:6 to 12 months (M6 to M12)
|
"utility" dimension (as a complement to the secondary criteria) of viability through the recovery mechanisms identified as successful mental health recovery
|
6 to 12 months (M6 to M12)
|
|
Viability and affordability
時間枠:6 to 12 months (M6 to M12)
|
Affordability for professionals and beneficiaries (financial, geographical, social and cultural levers and brakes of the intervention)
|
6 to 12 months (M6 to M12)
|
|
Viability and evaluability
時間枠:6 to 12 months (M6 to M12)
|
Evaluability of IACA: carrying out this evaluation, the availability of professionals and beneficiaries to answer questionnaires and interviews, missing data in the questionnaires etc.
|
6 to 12 months (M6 to M12)
|
|
Viability and adaptability
時間枠:6 to 12 months (M6 to M12)
|
Adaptability of IACA! (integration of the action into the context and the current organisation of the centres)
|
6 to 12 months (M6 to M12)
|
|
Viability and acceptability
時間枠:6 to 12 months (M6 to M12)
|
Acceptability of IACA! by professionals and beneficiaries
|
6 to 12 months (M6 to M12)
|
|
Feasibility study capacity
時間枠:12 months (M12)
|
The centres' capacity for inclusion (eligibility, recruitment rate, refusal rate)
|
12 months (M12)
|
|
Feasibility study complicance
時間枠:12 months (M12)
|
The compliance rates; understanding, acceptability and feasibility of study questionnaires and data collection tools;
|
12 months (M12)
|
|
Feasibility study ressources
時間枠:12 months (M12)
|
The ressources required (time required to complete all study forms, professional/centre capacity, etc.)
|
12 months (M12)
|
協力者と研究者
捜査官
- スタディチェア:Linda Cambon, PhD、Bordeaux University Hospital, Bordeaux University U1219
- スタディディレクター:François Alla, MD, PhD、Bordeaux University Hospital, Bordeaux University U1219
- スタディディレクター:Marc Auriacombe, MD, PhD、CNRS USR 3413 SANPSY, Bordeaux University, Bordeaux Hospital University
出版物と役立つリンク
一般刊行物
- Thabane L, Cambon L, Potvin L, Pommier J, Kivits J, Minary L, Nour K, Blaise P, Charlesworth J, Alla F; Discussion Panel. Population health intervention research: what is the place for pilot studies? Trials. 2019 May 30;20(1):309. doi: 10.1186/s13063-019-3422-4.
- Cambon L, Minary L, Ridde V, Alla F. Transferability of interventions in health education: a review. BMC Public Health. 2012 Jul 2;12:497. doi: 10.1186/1471-2458-12-497.
- Martin-Fernandez J, Stevens N, Moriceau S, Serre F, Blanc H, Latourte E, Auriacombe M, Cambon L. Realist evaluation of the impact, viability and transferability of an alcohol harm reduction support programme based on mental health recovery: the Vitae study protocol. BMJ Open. 2022 Aug 11;12(8):e065361. doi: 10.1136/bmjopen-2022-065361.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。